PUBLIKATIONEN
Impact of tumour volume and treatment delay on the outcome after linear accelerator-based fractionated stereotactic radiosurgery of uveal melanoma
Sreenivasa S., Wösle M., Gager Y., Vordermark D., Grajewski L., Krause L., Ciernik F.
Br J Ophthalmol: first published as 10.1136/bjo-2022-322750 on 9 March 2023.
Salvage radiation therapy for patients with relapsing glioblastoma multiforme and the role of slow fractionation.
Ciernik F., Gager Y., Renner C., Spieker S., Arndt S. & Neumann K.
Frontiers in Oncology, December 2020, Vol. 10., Article 577443, Original Research, published: 08 December 2020
Detection of ALK, RET, ROS1, NTRK1 and MET rearrangements and actionable mutations using Next Generation Sequencing in patients with Non-Small Cell Lung Cancer.
Harlé A., Dietmaier W., Vogl I., Neumann K., Haumaier F., Beggs A. D., Pestinger V., Grand D., Tallet A. & J.-L. Merlin.
MAP Congress - Molecular analysis for personalised therapy, Paris, France, 14-15 September 2018
Custom-based analyses in oncology using the programming language R.
Gager Y., Vogl I., Neumann K. & J. Gabert.
5. Dessauer Molekularpathologie Symposium, Dessau, Germany, 10 March 2018
Detecting fusion genes in NSCLC tumors using a NGS-targeted approach.
Vogl I., Gager Y., Werner L., Graef J., Birnbaum A., Schildhaus H.-U., Gabert J. & K. Neumann.
5. Dessauer Molekularpathologie Symposium, Dessau, Germany, 10 March 2018
Application of the transposase based SureSelectQXT protocol for BRCA1and BRCA2 FFPE sequencing.
Vogl I., Werner L., Held K., Neumann K. & J. Gabert.
4. Dessauer Molekularpathologie Symposium, Dessau, Germany, 12 March 2016